Showing results (11-20 of 741) with videos related to
Sort By:
Pageof 75
The Journal of Clinical Psychiatry|September 1, 1987
Neuropharmacology of the extrapyramidal systemR L Borison, B I DiamondBiological Psychiatry|April 1, 1978
A new animal model for schizophrenia: interactions with adrenergic mechanismsR L Borison, B I DiamondBrain Research Bulletin|August 1, 1983
Dyskinesias in the geriatric populationA J Blowers, R L BorisonThe Journal of the American Board of Family Practice|April 1, 1990
Movement disorders and new azapirone anxiolytic drugsM W Jann, J H Froemming, R L BorisonPsychopharmacology Bulletin|January 1, 1991
Does sigma receptor antagonism predict clinical antipsychotic efficacy?R L Borison, B I Diamond, A T DrenPsychopharmacology Bulletin|January 1, 1990
Efficacy and safety of a putative anxiolytic agent: ipsapironeR L Borison, J W Albrecht, B I DiamondNeurology|May 1, 1980
Estrogen in experimental tardive dyskinesiaJ H Gordon, R L Borison, B I DiamondBiological Psychiatry|June 1, 1980
Modulation of dopamine receptor sensitivity by estrogenJ H Gordon, R L Borison, B I DiamondJournal of Clinical Psychopharmacology|April 1, 1996
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study GroupR L Borison, L A Arvanitis, B G MillerPsychopharmacology Bulletin|January 1, 1994
Pharmacokinetics of risperidone in chronic schizophrenic patientsR L Borison, B Diamond, A Pathiraja, et al.Pageof 75